TENAX THERAPEUTICS, INC. (TENX) Return on equity 2016–2025
TENAX THERAPEUTICS, INC. (TENX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-54.2%FY2025 · since FY2016: -256.3% → -54.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -54.2% | -35.1 pp |
| FY2024 | -19.1% | — |
| FY2016 | -256.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More TENX financial trends
TENX RevenueTENX Net incomeTENX Net marginTENX Gross profitTENX Gross marginTENX Operating incomeTENX Operating marginTENX Operating cash flowTENX Free cash flowTENX Capital expendituresTENX Stock buybacksTENX Dividends paidTENX Total assetsTENX Total liabilitiesTENX Shareholders’ equityTENX overview →